The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Humana (HUM) backs reforms on extra Medicare Advantage payments from home visits and chart review. Read more here.

Q1 2026 Earnings Call Transcript June 3, 2025 HealthEquity, Inc. beats earnings expectations. Reported EPS is $0.97, ...

Blood products company Haemonetics (NYSE:HAE). in Q1 CY2025, with sales falling 3.7% year on year to $330.6 million. Its ...